Nvidia (NASDAQ:NVDA) stock gained on Monday after it announced that it has moved to expand its decade-long collaboration with OpenAI by signing a letter of intent for a strategic partnership. The ...
Microsoft stock has stagnated in recent weeks with questions over its cloud-computing growth and its relationship with OpenAI weighing on shares. But the stock still has plenty of room to rise, ...
Oklo Inc. (NYSE: OKLO) said on Thursday it has completed full-scale testing of a prototype fuel assembly at the U.S. Department of Energy's Argonne National Laboratory. The work was conducted through ...
Every time Samuel publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...
CoreWeave, a cloud services company that specializes in artificial intelligence, recently reached a $14.2 billion deal with Meta Platforms. CoreWeave stands out from traditional cloud platforms due to ...
Wolfspeed canceled its existing common stock and issued shares of a new stock earlier this week as part of its bankruptcy. Shareholders of the old stock received only one share for every 120 they ...
A recent U.S. Secret Service card skimming operation in Massachusetts is believed to have prevented $16.7 million in lost taxpayer dollars, according to the Secret Service. From Sept. 23 to 25, 12 ...
QCI raised $500 million in a private placement offering yesterday. The move will help fund the company's expansion. Follow-on offerings sometimes cause skepticism from investors. Investors sometimes ...
Nvidia (NVDA) stock jumped roughly 4% on Monday as the chipmaker announced it will invest up to $100 billion in OpenAI as part of a new partnership. Nvidia said in its announcement that the ...
Apple shares have been gaining in recent weeks on the back of seeming strength in iPhone 17 orders but Wall Street analysts see a mixed picture ahead.
After its best day in nearly four years Tuesday, Pfizer stock gave an encore performance. Shares of the drugmaker closed up 6.8% as investors digested Tuesday's news that Pfizer would get a three-year ...